Olsson Gisleskog, Per O. http://orcid.org/0000-0002-0706-8783
Perez Ruixo, Juan José http://orcid.org/0000-0001-9890-745X
Westin, Åke http://orcid.org/0000-0001-6125-8919
Hansson, Anna C. http://orcid.org/0000-0003-2357-5029
Soons, Paul A. http://orcid.org/0000-0001-6333-4938
Funding for this research was provided by:
McNeil AB, Helsingborg, Sweden
Article History
Accepted: 30 October 2020
First Online: 23 December 2020
Declarations
:
: SGS Exprimo NV was funded by McNeil AB, Helsingborg, Sweden to execute the work described in this article.
: Per O. Olsson Gisleskog performed the research while employed by SGS Exprimo NV, but has no conflicts of interest that are directly relevant to the content of this article. Juan José Perez Ruixo, Åke Westin, Anna C. Hansson and Paul A. Soons are (former) employees of affiliated companies of Johnson & Johnson.
: All clinical trials included in this research were approved by the Institutional Review Boards of the Universities of Lund (26 studies), Linköping (2 studies) or Gothenburg (1 study), Sweden.
: Informed consent was obtained from each subject, in all studies included in this research.
: Not applicable.
: Not applicable.
: Model codes are included in Electronic Supplemental Materials.
: All authors contributed to the research conception and design. Data collection was performed by AW and POG. Data analysis and research were performed by POG. The first draft of the manuscript was written by POG and PS. All authors commented on previous versions of the manuscript and read and approved the final manuscript.